SolaranRx

SolaranRx is a small, emerging growth company based in Albuquerque, New Mexico, with a team of three employees. Founded to address the unmet needs in metastatic melanoma treatment, SolaranRx is dedicated to developing innovative solutions within the biotechnology field. The company focuses on creating a new class of precision therapies and companion imaging agents specifically designed for metastatic melanoma. Their innovative Precision Theranostic Platform™ combines therapeutics and diagnostics, allowing for a targeted approach with minimal side effects. This unique platform aims to provide clinicians with powerful new tools and offer patients enhanced treatment options and improved outcomes. SolaranRx distinguishes itself through its distinctive mechanism of action, which aims to overcome the limitations of existing melanoma therapies. By merging therapeutics and diagnostics, they strive to deliver a more precise and effective treatment approach while minimizing potential adverse effects. This dedication to innovation and patient well-being sets SolaranRx apart in the field of cancer treatment. For more information about SolaranRx and its groundbreaking work in precision medicine, please visit their website at solaranrx.com.